Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Drug Targets Hundreds of Disorders

Magic bullet hits mutations that prompt 1,800 genetic diseases

By Peter Fearon,  Newser Staff

Posted Apr 23, 2007 8:42 AM CDT

(Newser) – A magic bullet that could treat cystic fibrosis, muscular dystrophy, hemophilia and more than 1,800 other genetic disorders could be available by 2009. Lee Sweeney of UPenn, leader of the team developing the drug, tells the Times of London: “It doesn’t just target one mutation that causes disease, but a whole class of mutations.”

The breakthrough drug, known as PTC124, works by helping genes to ignore disruptions to genetic code caused by "nonsense mutations," allowing cells to develop normally. It can be used against a wide range of disorders caused by the same kind of mutation. The daily pill enters the last phase of trials on humans this year.

A lab officer cuts a DNA fragment under UV light from an agarose gel for DNA sequencing as part of research to determine genetic mutation in a blood cancer patient, Thursday April 19, 2007 in Singapore, which prides itself as an advanced medical treatment and research hub. The number of...
A lab officer cuts a DNA fragment under UV light from an agarose gel for DNA sequencing as part of research to determine genetic mutation in a blood cancer patient, Thursday April 19, 2007 in Singapore,...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

More Newser Stories

Breast Cancer Risk Seen for Latinos, Blacks

Genes Give Up Secrets of 7 Serious Diseases

New Procedure Gives Hope to Diabetics

New Genetic Ties to MS Found

Early Immunity to Chimp Virus Leaves Humans Open to HIV


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne